TrialBlood advances2026

HLHRUXO: a prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.

Lauren K Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.